Accuracy of pathologic examination in detection of complete response after chemoradiation for esophageal cancer

American Journal of Surgery

Volumn 193, Issue 5 SPEC. ISS., 2007, Pages 614-617

  Chang, Eugene Y ^a   Smith, Christina A ^a   Corless, Christopher L ^a   Thomas Jr , Charles R ^b   Hunter, John G ^a   Jobe, Blair A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Esophageal cancer; Neoadjuvant chemoradiation; Pathologic complete response; Staging

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 34147130310     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.01.002     Document Type: Article

References (29)

1. Jemal A., Tiwari R.C., Murray T., et al. Cancer statistics, 2004. CA Cancer J Clin 54 (2004) 8-29
2. Daly J.M., Karnell L.H., and Menck H.R. National Cancer Data Base report on esophageal carcinoma. Cancer 78 (1996) 1820-1828
3. Ide H., Nakamura T., Hayashi K., et al. Esophageal squamous cell carcinoma: pathology and prognosis. World J Surg 18 (1994) 321-330
4. Torres C., Turner J.R., Wang H.H., et al. Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients. Cancer 85 (1999) 520-528
5. Walsh T.N., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335 (1996) 462-467
6. Mooney M.M. Neoadjuvant and adjuvant chemotherapy for esophageal adenocarcinoma. J Surg Oncol 92 (2005) 230-238
7. Swisher S.G., Hofstetter W., Wu T.T., et al. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 241 (2005) 810-817 discussion 817-20
8. Donington J.S., Miller D.L., Allen M.S., et al. Tumor response to induction chemoradiation: influence on survival after esophagectomy. Eur J Cardiothorac Surg 24 (2003) 631-636 discussion 636-7
9. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
10. Swisher S.G., Ajani J.A., Komaki R., et al. Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 57 (2003) 120-127
11. Berger A.C., Farma J., Scott W.J., et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 23 (2005) 4330-4337
12. Roth J.A., Pass H.I., Flanagan M.M., et al. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 96 (1988) 242-248
13. Kelsen D.P., Ginsberg R., Pajak T.F., et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339 (1998) 1979-1984
14. Urba S.G., Orringer M.B., Turrisi A., et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 (2001) 305-313
15. Weaver D.L., Krag D.N., Ashikaga T., et al. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer 88 (2000) 1099-1107
16. Wong S.L., Chao C., Edwards M.J., et al. The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer. Am J Surg 182 (2001) 330-334
17. Czerniecki B.J., Scheff A.M., Callans L.S., et al. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 85 (1999) 1098-1103
18. Viale G., Maiorano E., Mazzarol G., et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 92 (2001) 1378-1384
19. Viale G., Sonzogni A., Pruneri G., et al. Histopathologic examination of axillary sentinel lymph nodes in breast carcinoma patients. J Surg Oncol 85 (2004) 123-128
20. Pargaonkar A.S., Beissner R.S., Snyder S., and Speights Jr. V.O. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch Pathol Lab Med 127 (2003) 701-705
21. Langer I., Marti W.R., Guller U., et al. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg 241 (2005) 152-158
22. Friedman S., Bertin F., Mouriesse H., et al. Importance of tumor cells in axillary node sinus margins ('clandestine' metastases) discovered by serial sectioning in operable breast carcinoma. Acta Oncol 27 (1988) 483-487
23. de Mascarel I., Bonichon F., Coindre J.M., and Trojani M. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 66 (1992) 523-527
24. Clayton F., and Hopkins C.L. Pathologic correlates of prognosis in lymph node-positive breast carcinomas. Cancer 71 (1993) 1780-1790
25. Hainsworth P.J., Tjandra J.J., Stillwell R.G., et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 80 (1993) 459-463
26. McGuckin M.A., Cummings M.C., Walsh M.D., et al. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 73 (1996) 88-95
27. O'Sullivan G.C., Sheehan D., Clarke A., et al. Micrometastases in esophagogastric cancer: high detection rate in resected rib segments. Gastroenterology 116 (1999) 543-548
28. Ryan P., McCarthy S., Kelly J., et al. Prevalence of bone marrow micrometastases in esophagogastric cancer patients with and without neoadjuvant chemoradiotherapy. J Surg Res 117 (2004) 121-126
29. Thorban S., Roder J.D., Nekarda H., et al. Disseminated epithelial tumor cells in bone marrow of patients with esophageal cancer: detection and prognostic significance. World J Surg 20 (1996) 567-572 discussion 572-3